{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:10:04Z","timestamp":1788786604164,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Polycystic ovary syndrome (PCOS) is closely associated with insulin resistance, metabolic syndrome (MetS), and non-alcoholic fatty liver disease (NAFLD); however, whether fatty pancreas disorder is also more common in PCOS remains insufficiently clarified. This study aimed to compare the frequency of hepatic and fatty pancreas disorder and tissue stiffness between women with PCOS and a healthy control group and to determine the relationship of these findings with metabolic and biochemical parameters. Methods: In this retrospective case\u2013control study, 40 women diagnosed with PCOS according to the 2003 Rotterdam criteria and 40 age- and body mass index (BMI)-matched healthy women were evaluated by abdominal ultrasonography and two-dimensional shear wave elastography (2D-SWE) of the liver and pancreas. Four validated non-invasive indices of hepatic steatosis (NAFLD liver fat score, lipid accumulation product [LAP], hepatic steatosis index [HSI], FIB-4, APRI) were calculated and correlated with clinical, anthropometric, and biochemical data. MetS was defined according to International Diabetes Federation (IDF) criteria. Results: Fatty pancreas disorder was detected in 47.5% of PCOS patients versus 17.5% of controls (p = 0.008); hepatic steatosis was found in 37.5% and 15%, respectively (p = 0.04); these differences were observed despite similar age and BMI between groups. LAP and HSI scores were higher in the PCOS group (p = 0.02 and p = 0.005, respectively), as were serum triglyceride and total testosterone levels (p = 0.001 and p = 0.005, respectively). Overall MetS frequency did not differ between the PCOS and control groups (p = 0.61) but was significantly higher among participants with fatty pancreas disorder (p = 0.009) and hepatic steatosis (p = 0.05). Hepatic and pancreatic 2D-SWE values were significantly higher in participants with steatosis than in those without (p = 0.02 and p = 0.04, respectively), and both correlated positively with BMI (p &lt; 0.001 and p = 0.003, respectively). Conclusions: The frequency of fatty pancreas disorder and hepatic steatosis is increased in women with PCOS independent of obesity, and both are associated with a higher frequency of MetS; the association between fatty pancreas disorder and PCOS remained significant in a multivariable analysis adjusted for BMI. Fatty pancreas disorder showed a stronger association with MetS, suggesting that it may serve as an early, low-cost, ultrasound-detectable marker of metabolic risk in PCOS and warrants systematic evaluation alongside hepatic steatosis.<\/jats:p>","DOI":"10.3390\/jcm15176772","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:45:13Z","timestamp":1788241513000},"page":"6772","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polycystic Ovary Syndrome Is Associated with Fatty Pancreas Disorder: A Case\u2013Control Study in Non-Diabetic Women"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5795-6539","authenticated-orcid":false,"given":"Halil","family":"Severoglu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Mersin University, 33343 Mersin, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehmi","family":"Ate\u015f","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Mersin University, 33343 Mersin, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5894-3421","authenticated-orcid":false,"given":"Huseyin","family":"Durukan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Mersin University, 33343 Mersin, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.fertnstert.2016.05.009","article-title":"Introduction: Determinants of polycystic ovary syndrome","volume":"106","author":"Azziz","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","article-title":"The role of genes and environment in the etiology of PCOS","volume":"30","author":"Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5455\/medarh.2020.74.289-293","article-title":"Follicle Stimulating Hormone (LH:FSH) Ratio in Polycystic Ovary Syndrome (PCOS)\u2014Obese vs. Non-Obese Women","volume":"74","author":"Saadia","year":"2020","journal-title":"Med. Arch."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"ref_9","first-page":"100060","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD)\u2014Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ra\u0111enovi\u0107, S.S., Pupovac, M., Andji\u0107, M., Bila, J., Sre\u0107kovi\u0107, S., Gudovi\u0107, A., Draga\u0161, B., and Radunovi\u0107, N. (2022). Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS). Biomedicines, 10.","DOI":"10.3390\/biomedicines10010131"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.3748\/wjg.v22.i34.7660","article-title":"Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease","volume":"22","author":"Catanzaro","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/s0004-2803.202000000-27","article-title":"Pancreatic Steatosis: A New Diagnosis and Therapeutic Challenge in Gastroenterology","volume":"57","author":"Paul","year":"2020","journal-title":"Arq. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","article-title":"Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease","volume":"39","author":"Smits","year":"2010","journal-title":"Pancreas"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fajki\u0107, A., Lam, Y.W., Jahi\u0107, R., \u0106avar, I., Markoti\u0107, A., and Belan\u010di\u0107, A. (2026). From Adipose Dysfunction to Multi-Organ Steatosis: Defining the Metabolic Steatotic Axis. Curr. Issues Mol. Biol., 48.","DOI":"10.3390\/cimb48020178"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Petrov, M.S., Yamazaki, H., Lu, G., Al-Mrabeh, A.H., Luchini, C., Dong, X., Hamada, T., Liu, Y., Oyama, H., and Rospleszcz, S. (2026). Conceptual framework and expert guidance on intrapancreatic fat deposition: The Melbourne consensus. Nat. Rev. Gastroenterol. Hepatol., Epub ahead of print.","DOI":"10.1038\/s41575-026-01224-6"},{"key":"ref_22","unstructured":"Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates. [2nd ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0025-6196(11)60770-2","article-title":"A practical \u201cABCDE\u201d approach to the metabolic syndrome","volume":"83","author":"Blaha","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014A new world-wide definition: A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Kahn, H.S., Bellentani, S., and Tiribelli, C. (2010). A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol., 10.","DOI":"10.1186\/1471-230X-10-98"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"ref_29","first-page":"477","article-title":"APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"S. Afr. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.physbeh.2007.11.049","article-title":"Lipid accumulation in non-adipose tissue and lipotoxicity","volume":"94","year":"2008","journal-title":"Physiol. Behav."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2016.12.012","article-title":"Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression","volume":"69","author":"Singh","year":"2017","journal-title":"Metabolism"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.12688\/f1000research.16815.1","article-title":"Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS","volume":"8","author":"Hestiantoro","year":"2019","journal-title":"F1000Research"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00535-020-01683-x","article-title":"Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: A 6-year computed tomography-based cohort study","volume":"55","author":"Yamazaki","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10620-021-06844-3","article-title":"Pancreatic Steatosis Is Associated with Both Metabolic Syndrome and Pancreatic Stiffness Detected by Ultrasound Elastography","volume":"67","author":"Sezgin","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pan.2021.01.003","article-title":"Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients","volume":"21","author":"Hoogenboom","year":"2021","journal-title":"Pancreatology"},{"key":"ref_39","first-page":"e23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis","volume":"14","author":"Motalebi","year":"2014","journal-title":"Hepat. Mon."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: A novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: An updated meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1038\/s41598-023-39428-4","article-title":"Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome","volume":"13","author":"Hong","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_610_18","article-title":"Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome","volume":"151","author":"Chakraborty","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e3142","DOI":"10.1002\/dmrr.3142","article-title":"The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis","volume":"35","author":"Bi","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.gastha.2022.01.007","article-title":"Association of Pancreatic Fatty Infiltration with Age and Metabolic Syndrome Is Sex-Dependent","volume":"1","author":"Bhalla","year":"2022","journal-title":"Gastro Hep Adv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00105-020-04677-1","article-title":"Hyperandrogenism, adrenal dysfunction, and hirsutism","volume":"71","author":"Makrantonaki","year":"2020","journal-title":"Hautarzt"},{"key":"ref_48","first-page":"237","article-title":"Hirsutism","volume":"82","author":"Fanta","year":"2017","journal-title":"Ceska Gynekol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1530\/EC-20-0527","article-title":"Higher blood pressure in normal weight women with PCOS compared to controls","volume":"10","author":"Mellembakken","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.18650","article-title":"Ultrasound Elastography: Review of Techniques and Clinical Applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.diii.2013.01.022","article-title":"Ultrasound elastography: Principles and techniques","volume":"94","author":"Gennisson","year":"2013","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.25756","article-title":"Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases","volume":"56","author":"Ochi","year":"2012","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Chimoriya, R., Piya, M.K., Simmons, D., Ahlenstiel, G., and Ho, V. (2020). The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010095"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.pan.2021.07.006","article-title":"The course and prognostic value of increased pancreas stiffness detected by ultrasound elastography during acute pancreatitis","volume":"21","author":"Sezgin","year":"2021","journal-title":"Pancreatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6772\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:36:28Z","timestamp":1788784588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":55,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176772"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176772","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}